U. Bosse

Grading of Tumor Regression in Non-small Cell Lung Cancer

Klaus Junker, K. Langner, F. Klinke et al. · CHEST Journal · 2001 · 176 citations

Tumor Regression, Cancer Detection, Medicine +8

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment

Klaus Junker, Michael Thomas, Karsten Schulmann et al. · Journal of Cancer Research and Clinical Oncology · 1997 · 166 citations · Full text

Histological Assessment, Non-small-cell Lung Cancer, Neoadjuvant Therapy +11

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

C. M. Schlotter, U Vogt, U. Bosse et al. · Breast Cancer Research · 2003 · 71 citations · Full text

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid

U Vogt, Krzysztof Piotr Bielawski, U. Bosse et al. · Oncology Reports · 2004 · 52 citations

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer1Published in conjunction with A Wisconsin Gathering Honoring Waclaw Szybalski on the occasion of his 75th year and 20 years of Editorship-in-Chief of Gene, 10–11 August, 1997, University of Wisconsin, Madison, WI, USA.1

U Vogt, Krzysztof Piotr Bielawski, C. M. Schlotter et al. · Gene · 1998 · 44 citations

Breast Oncology, Engineering, Cancer Biology +18